Puromycin reactivity does not accurately localize translation at the subcellular level
Puromycin is a tyrosyl-tRNA mimic that blocks translation by labeling and releasing elongating polypeptide chains from translating ribosomes. Puromycin has been used in molecular biology research for decades as a translation inhibitor. The development of puromycin antibodies and derivatized puromyci...
Main Authors: | Syed Usman Enam, Boris Zinshteyn, Daniel H Goldman, Madeline Cassani, Nathan M Livingston, Geraldine Seydoux, Rachel Green |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-08-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/60303 |
Similar Items
-
The science of puromycin: From studies of ribosome function to applications in biotechnology
by: Ranen Aviner
Published: (2020-01-01) -
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish
by: Soonil Koun, et al.
Published: (2023-12-01) -
Puromycin aminonucleoside modulates p130Cas of podocytes
by: Tae-Sun Ha, et al.
Published: (2012-10-01) -
Puromycin aminonucleoside‐induced podocyte injury is ameliorated by the Smad3 inhibitor SIS3
by: Lina Jiang, et al.
Published: (2020-08-01) -
Puromycin aminonucleoside triggers apoptosis in podocytes by inducing endoplasmic reticulum stress
by: Seo-Yoon Min, et al.
Published: (2018-09-01)